Child Guidelines Psychotherapeutic Medication Guidelines 2018 – 2019 Florida Best Practice Psychotherapeutic Medication Guidelines for Children and Adolescents 2018 – 2019 Antipsychotic High Dosing Table for Children and Adolescents Read More 2018 – 2019 Principles of Practice Regarding the Use of Psychotropic Medication in Children and Adolescents 6 to 17 Years Old Read More 2018 – 2019 Principles of Practice Regarding the Use of Psychotropic Medication in Children Under Age 6 Read More 2018 – 2019 ADHD Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Aggression Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Anxiety Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Bipolar Disorders Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Insomnia Disorder Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Major Depression Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Monitoring Side-Effects of Antipsychotic Medication in Children and Adolescents Read More 2018 – 2019 Obsessive-Compulsive Disorder Medication Guidelines for Children and Adolescents Read More 2018 – 2019 PTSD Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Schizophrenia Medication Guidelines for Children and Adolescents Read More 2018 – 2019 Tic Disorders Medication Guidelines for Children and Adolescents Read More ASD & ID Guidelines 2019 Autism Spectrum Disorder & Intellectual Developmental Disorder: Florida Best Practice Psychotherapeutic Medication Recommendations for Target Symptoms 2019 Principles of Practice in the Context of ASD & ID Read More 2019 Special Considerations in Children under Age 6 with ASD & ID Read More 2019 Adverse Effect Management During Atypical Antipsychotic Treatment in Youths with ASD & ID Read More 2019 Complementary and Alternative Treatments for Children with ASD Read More 2019 Medication Optimization and Deprescribing in Children and Adolescents with ASD & ID Read More 2019 Treatment of Aggression in the Context of ASD & ID Read More 2019 Treatment of Anxiety in the Context of ASD & ID Read More 2019 Treatment of Catatonia in the Context of ASD & ID Read More 2019 Treatment of Depression or Bipolar Disorder in the Context of ASD & ID Read More 2019 Treatment of Hyperactive, Impulsive, and Inattentive Symptoms in the Context of ASD & ID Read More 2019 Treatment of Psychosis in the Context of ASD & ID Read More 2019 Treatment of Restricted, Repetitive Behaviors in the Context of ASD & ID Read More 2019 Treatment of Sleep Disturbances in the Context of ASD & ID Read More 2019 Use of Psychotherapeutic Medications and Routine Monitoring in the Context of ASD & ID Read More
2018 – 2019 Principles of Practice Regarding the Use of Psychotropic Medication in Children and Adolescents 6 to 17 Years Old Read More
2018 – 2019 Principles of Practice Regarding the Use of Psychotropic Medication in Children Under Age 6 Read More
2018 – 2019 Monitoring Side-Effects of Antipsychotic Medication in Children and Adolescents Read More
2018 – 2019 Obsessive-Compulsive Disorder Medication Guidelines for Children and Adolescents Read More
2019 Adverse Effect Management During Atypical Antipsychotic Treatment in Youths with ASD & ID Read More
2019 Treatment of Hyperactive, Impulsive, and Inattentive Symptoms in the Context of ASD & ID Read More
2019 Use of Psychotherapeutic Medications and Routine Monitoring in the Context of ASD & ID Read More